October 3, 2026
Uncategorized

Brokerages see near-term upside in Dr Reddy’s on Semaglutide, ex-US growth (Soban News)

Dr Reddy’s Laboratories reported a consolidated Q2FY26 net profit of ₹1,437.2 crore, up 14 per cent Y-o-Y from ₹1,255.3 crore, with sequential growth largely flat.​Dr Reddy’s Laboratories reported a consolidated Q2FY26 net profit of ₹1,437.2 crore, up 14 per cent Y-o-Y from ₹1,255.3 crore, with sequential growth largely flat. ​Latest News [ SOBAN NEWS: International and National ]

Related posts

We’re closing up Democrat programmes, says Trump amid ongoing govt shutdown (Soban News)

News-Soban-Admin

Javier Milei’s libertarian party wins Argentina’s midterm elections (Soban News)

News-Soban-Admin

Best of BS Opinion: India, US must push for a quick trade agreement (Soban News)

News-Soban-Admin

Leave a Comment